Webinar: Analyzing the Legacy of Henrietta Lacks

Analyzing the Legacy of Henrietta Lacks

In 1951, a young black woman named Henrietta Lacks was diagnosed with cervical cancer. During her treatment, her doctor took a sample of her cells and tried to grow them in culture. The cells, called HeLa cells, were the first human cells that could be grown in a laboratory and are still the most widely studied cells in biomedical research, having led to treatments for diseases such as polio, HIV, and cancer.

Join the webinar on Wednesday, November 13, 11:00-12:00 PM EST, where Chris Belter, Informationist at the NIH Library, National Institutes of Health, will discuss how he used advanced analytics and Research Intelligence solutions to analyze the research fields and impact that has resulted from the use of HeLa cells, an approach that can be used to investigate the impact of other research areas as well.

To register: https://www.brighttalk.com/webcast/13819/372502

Share this Post

This site uses Akismet to reduce spam. Learn how your comment data is processed.